logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Bipolar I Disorder

    Medications for Bipolar I Disorder

    FiltersReset Filters
    37 results

    • abilify asimtufii

      (Aripiprazole)
      Otsuka America Pharmaceutical, Inc
      Usage: ABILIFY ASIMTUFII is indicated for the treatment of schizophrenia in adults and for maintenance monotherapy of bipolar I disorder in adults.

    • abilify maintena

      (aripiprazole)
      Otsuka America Pharmaceutical, Inc.
      Usage: ABILIFY MAINTENA (aripiprazole) is indicated for the treatment of schizophrenia and as maintenance monotherapy for bipolar I disorder in adults.

    • aripiprazole

      (Aripiprazole)
      Advagen Pharma Ltd
      Usage: Aripiprazole Oral Solution is indicated for the treatment of schizophrenia, acute manic and mixed episodes of Bipolar I Disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and Tourette’s disorder.

    • asenapine

      (ASENAPINE)
      Sigmapharm Laboratories, LLC
      Usage: Asenapine sublingual tablets are indicated for the adjunctive treatment of Bipolar I disorder in adults, specifically in combination with lithium or valproate.

    • fanapt

      (iloperidone)
      Vanda Pharmaceuticals Inc.
      Usage: FANAPT® is indicated for the treatment of schizophrenia in adults and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.

    • fluoxetine

      (Fluoxetine Hydrochloride)
      Aurobindo Pharma Limited
      Usage: Fluoxetine capsules are indicated for the treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. In combination with Olanzapine, they also treat depressive episodes in Bipolar I Disorder and treatment-resistant depression. Monotherapy with fluoxetine is not approved for Bipolar I or treatment-resistant depression.

    • fluoxetine

      (Fluoxetine Hydrochloride)
      ScieGen Pharmaceuticals, Inc.
      Usage: Fluoxetine is indicated for the treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. In combination with Olanzapine, it is used for depressive episodes in Bipolar I Disorder and treatment-resistant depression. Monotherapy with fluoxetine is not suitable for these latter conditions.

    • lamotrigine

      (Lamotrigine)
      Aurobindo Pharma Limited
      Usage: Lamotrigine tablets for oral suspension are indicated as adjunctive therapy for partial-onset, primary generalized tonic-clonic, and Lennox-Gastaut seizures in patients aged 2 and older. They are also used for maintaining bipolar I disorder, delaying mood episode occurrences, but not for treating acute episodes.

    • lamotrigine

      (Lamotrigine)
      Taro Pharmaceuticals U.S.A., Inc.
      Usage: Lamotrigine is indicated as adjunctive therapy for partial-onset, primary generalized tonic-clonic, and Lennox-Gastaut syndrome seizures in patients aged 2 and older, and for conversion to monotherapy in adults with partial-onset seizures. It is also used for the maintenance treatment of bipolar I disorder to delay mood episodes.

    • lamotrigine

      (Lamotrigine)
      Northstar Rx LLC.
      Usage: Lamotrigine is indicated as adjunctive therapy for partial-onset seizures, primary generalized tonic-clonic seizures, and Lennox-Gastaut syndrome seizures in patients aged 2 and older. It is also used for the maintenance treatment of bipolar I disorder to delay mood episodes, but not for acute episodes.